Filip Scheperjans

Brain-first and body-first Parkinson’s disease: are there subgroups of prodromal patients? 9:12
Brain-first and body-first Parkinson’s disease: are there subgroups of prodromal patients?
Filip Scheperjans • 1 Jun 2021
Microbiota-targeting agents for Parkinson’s disease 1:52
Microbiota-targeting agents for Parkinson’s disease
Filip Scheperjans • 1 Jun 2021
Can we achieve a clinically actionable test of the gut microbiome for neurodegenerative disorders? 3:21
Can we achieve a clinically actionable test of the gut microbiome for neurodegenerative disorders?
Filip Scheperjans • 1 Jun 2021
Investigating the gut microbiome in Parkinson’s disease 2:59
Investigating the gut microbiome in Parkinson’s disease
Filip Scheperjans • 1 Jun 2021
Proof of concept trial: fecal microbiome transplantation in Parkinson’s disease 3:30
Proof of concept trial: fecal microbiome transplantation in Parkinson’s disease
Filip Scheperjans • 1 Jun 2021
The content of VJNeurology is intended for healthcare professionals